FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Sanofi-Aventis news from FierceBioResearcher

News

Sanofi turns to China for R&D partnerships

The R&D wing at Sanofi-Aventis is turning to China to find new ways to fight cancer and rheumatoid arthritis. The French pharma giant wants to forge a half dozen research partnerships with Read more...

Foot-and-mouth outbreak linked to research lab

A private laboratory in England is the prime suspect in the recent outbreak of foot-and-mouth disease. UK officials believe that a breakdown in procedures at Merial Animal Health--which is jointly Read more...

Press Releases

PRESS RELEASE: Regeneron Initiates Major Global Collaboration with Sanofi-aventis

Regeneron Initiates Major Global Collaboration with Sanofi-aventis to Develop and Commercialize Fully-Human Therapeutic Antibodies Sanofi-aventis plans to increase its stake in Regeneron to Read more...

Sanofi-aventis Announces New Research Center in Oro Valley

ORO VALLEY, Ariz., Nov. 15 /PRNewswire-FirstCall/ -- Sanofi-aventis, a leading global pharmaceutical company, hosted a groundbreaking ceremony today for a new Research Center in Oro Valley. The Read more...

PRESS RELEASE: Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Sanofi-Aventis

Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Sanofi-Aventis NEW YORK -- Coughlin Stoia Geller Rudman & Robbins LLP (“Coughlin Stoia”) (Read more...

PRESS RELEASE: Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine

Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine SWIFTWATER, Pa., and LYON, France, Nov. 7 -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, Read more...

PRESS RELEASE: FDA Sends Sanofi Warning Letter for Ketek Study

FDA Sends Sanofi Warning Letter for Ketek Study ROCKVILLE, Md., Oct. 24, 2007--The FDA posted on its web site a letter to Sanofi-aventis regarding a study with the antibiotic Ketek. DEPARTMENT OF Read more...

Get more Sanofi-Aventis coverage at: